Living Legends in Psychopharmacology: From Evidence Base to Advances in Treatment 2023 (CME VIDEOS)

Overview

Living Legends in Psychopharmacology: From Evidence Base to Advances in Treatment 2023 (CME VIDEOS) focuses on the treatment of common psychiatric conditions with particular attention to difficult-to-treat and treatment-resistant cases. This program enhances clinical decision-making by exploring the interface between psychiatric, neurological, and medical illnesses through continuing medical education lectures.

On-demand psychiatry education — accessible anytime, anywhere.

Agenda

This CME video series reviews current evidence-based and emerging treatment strategies across a spectrum of psychiatric disorders. Content includes expert presentations and panel discussions covering clinical advances and challenges in psychopharmacology.

• Lessons Learned from the DNA of Patients with Psychiatric Disorders — Daniel Weinberger, MD
• Neurology and Psychiatry Interface — Martin Samuels, MD, DSc (hon)
• The Interface of Medical and Psychiatric Disorders – Focus on Cancer and Heart Disease — Charles Nemeroff, MD, PhD
• Tackling Unsolved Problems in the Pharmacological Treatment of Schizophrenia – Cognitive Impairment, Negative Symptoms, and Partial Treatment Response — Philip Harvey, PhD
• Panel Discussion — Philip Harvey, PhD; Charles Nemeroff, MD, PhD; Martin Samuels, MD, DSc (hon); Daniel Weinberger, MD
• Pharmacological Treatment of Bipolar Disorder — Ross Baldessarini, MD, DSc (hon)
• Anxiety – Treat the Symptom or Treat the Disorder When First Line Therapies Fail — Stephen Stahl, MD, PhD, DSc (hon)
• Neurobiology and Treatment of Post-traumatic Stress Disorder — Charles Nemeroff, MD, PhD
• Panel Discussion — Ross Baldessarini, MD, DSc (hon); Charles Nemeroff, MD, PhD
• Psychopharmacologic Treatment of Sleep Disorders — Sogol Javaheri, MD
• Treatment Resistant Depression — Stephen Stahl, MD, PhD, DSc (hon)
• Psychedelics and Potential Drugs of Abuse as Antidepressants — Alan Schatzberg, MD
• Pharmacotherapy of Substance Use Disorders — Roger Weiss, MD
• Panel Discussion — Barbara Coffey, MD, MS; Sogol Javaheri, MD; Alan Schatzberg, MD; Stephen Stahl, MD, PhD, DSc (hon); Roger Weiss, MD
• Child and Adolescent Psychopharmacology – Current Treatment for Best Practices — Barbara Coffey, MD, MS
• Psychopharmacology Across the Reproductive Lifespan – From Menarche to Menopause — Ariadna Forray, MD
• Geriatric Psychopharmacology — Elizabeth Crocco, MD
• Panel Discussion — Barbara Coffey, MD, MS; Elizabeth Crocco, MD; Ariadna Forray, MD

Learning Objectives

At the completion of this course, you should be able to:

• Describe lessons learned from genomic sequencing of patients with psychiatric illnesses
• Identify unsolved problems regarding the pharmacologic treatment of schizophrenia and approaches to more effective treatments
• Describe emerging theories and treatments of bipolar disorder, difficult-to-treat depression, bipolar depression, and anxiety disorder
• Outline the perils and possibilities of psychedelics and ketamine in psychiatric treatment
• Recognize when to utilize ECT and TMS for treatment-resistant depression
• Illustrate emerging treatments for PTSD
• Review sleep disorders commonly comorbid with psychiatric illness and the appropriate use of medications and treatments
• Review the interface of medicine and psychiatry focusing on cancer and cardiovascular disease
• Review the interface between neurology and psychiatry emphasizing functional neurological disease, hysteria, movement disorders, pain, OCD, and others
• Summarize the use of genetic tests, serum level measurements, and drug combinations in treatment-resistant depression
• Identify the current role of pharmacotherapy in substance use disorders including alcohol, opioids, and cannabis
• Review pharmacotherapy in psychiatric disorders throughout the female reproductive lifespan, including premenstrual, prenatal, postpartum, and perimenopausal periods
• Examine the latest advances and challenges in treatment approaches for child, adolescent, and geriatric populations

Speakers

• Daniel Weinberger, MD
• Martin Samuels, MD, DSc (hon)
• Charles Nemeroff, MD, PhD
• Philip Harvey, PhD
• Ross Baldessarini, MD, DSc (hon)
• Stephen Stahl, MD, PhD, DSc (hon)
• Sogol Javaheri, MD
• Alan Schatzberg, MD
• Roger Weiss, MD
• Barbara Coffey, MD, MS
• Ariadna Forray, MD
• Elizabeth Crocco, MD

Target Audience

This course is designed for psychiatrists, neurologists, addiction medicine specialists, and other mental health professionals seeking to deepen their understanding of psychopharmacology. It is also suitable for clinicians managing complex and treatment-resistant psychiatric disorders and those interested in advances spanning neurobiology and clinical therapeutics.

Why This Topic Matters

Living Legends in Psychopharmacology: From Evidence Base to Advances in Treatment 2023 (CME VIDEOS) addresses critical topics in psychopharmacology relevant to psychiatry and related specialties. It provides a comprehensive update on pharmacologic treatment advances and the intersection of psychiatric care with neurological and medical conditions.

Available through MedHub Central, this program supports clinicians in strengthening their expertise and confidence in applying evidence-based approaches to complex psychiatric cases, ultimately promoting informed patient care within the neuropsychiatric field.